KORU Medical Systems (NASDAQ:KRMD) Rating Increased to Strong-Buy at B. Riley

KORU Medical Systems (NASDAQ:KRMD) was upgraded by equities research analysts at B. Riley to a “strong-buy” rating in a research note issued to investors on Thursday,Zacks.com reports.

Other research analysts have also issued reports about the stock. Piper Sandler reaffirmed a “neutral” rating and set a $4.50 price objective on shares of KORU Medical Systems in a research note on Friday, February 14th. Craig Hallum lifted their price target on shares of KORU Medical Systems from $5.00 to $6.00 and gave the stock a “buy” rating in a research note on Friday, January 17th. Lake Street Capital upped their price target on shares of KORU Medical Systems from $4.00 to $5.00 and gave the company a “buy” rating in a report on Tuesday, January 14th. Finally, Canaccord Genuity Group increased their price target on KORU Medical Systems from $3.00 to $4.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. One analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $4.70.

KORU Medical Systems Price Performance

Shares of KORU Medical Systems stock opened at $2.77 on Thursday. The stock has a market cap of $126.97 million, a price-to-earnings ratio of -11.08 and a beta of 0.74. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.37 and a current ratio of 2.99. The stock has a 50 day moving average price of $3.94 and a 200-day moving average price of $3.39. KORU Medical Systems has a one year low of $2.04 and a one year high of $5.05.

Hedge Funds Weigh In On KORU Medical Systems

Hedge funds have recently added to or reduced their stakes in the stock. Connor Clark & Lunn Investment Management Ltd. grew its stake in KORU Medical Systems by 77.7% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 61,412 shares of the company’s stock worth $168,000 after purchasing an additional 26,860 shares in the last quarter. XTX Topco Ltd bought a new position in shares of KORU Medical Systems during the 3rd quarter worth $34,000. Geode Capital Management LLC grew its position in shares of KORU Medical Systems by 6.5% during the 3rd quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock worth $1,262,000 after buying an additional 28,323 shares in the last quarter. Empire Financial Management Company LLC purchased a new position in shares of KORU Medical Systems during the third quarter valued at $259,000. Finally, Calamos Advisors LLC bought a new stake in shares of KORU Medical Systems in the fourth quarter valued at about $250,000. 58.60% of the stock is currently owned by institutional investors.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.